Search companies

Live

Tuesday, 17 November 2026 · 583 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Entropy Wins South African Psilocin Patent Protection Through 2043

ENP: $0.029 +0.00% · MC: $47M

Entropy Neurodynamics has secured a South African patent covering proprietary crystalline forms of psilocin, extending protection through 2043 and adding to a corresponding Australian patent granted earlier this year. The company says the patent complements its TRP-8803 development program and is intended to support future development, licensing and partnership opportunities.

Source announcements: 2026-11-09 08:56 to 2026-11-09 08:56 Sydney time
Story updated 2026-11-09 09:03 Sydney time
SourcesEntropy Secures South African Psilocin Patent to 2043
Comments